• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Aldeyra Therap(ALDX.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Nov6
Aldeyra Therapeutics released FY2025 Q3 earnings on November 5, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.1278 (forecast EPS USD -0.245)
04:00
Aldeyra Therapeutics released FY2025 9 Months Earnings on November 5, 2025 (EST), actual revenue USD 0, actual EPS USD -0.4584
04:00
Oct29
Aldeyra Therapeutics Ends ADX-629 Development Focusing on Next-Gen Candidates
11:32
Oct28
Aldeyra Therapeutics Inc. reports positive results for its drug in hepatitis trial
11:04
Aug8
Aldeyra Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1626 (forecast USD -0.2433)
03:00
Aldeyra Therap released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD -0.3284
03:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.688 M, EPS -0.1278

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -9.767 M, EPS -0.1626

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.93 M, EPS -0.1658

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LVRO
1.100
+144.44%
+0.650
SKYQ
0.4305
+92.62%
+0.207
BNAI
3.770
+62.50%
+1.450
DVLT
1.010
+54.88%
+0.358
NTCL
0.5301
+53.43%
+0.185
ATLN
2.040
+53.38%
+0.710
UAVS
1.230
+51.14%
+0.416
PLRZ
12.750
+50.18%
+4.260
GPUS
0.2730
+48.69%
+0.089
TBMCR
0.3600
+48.39%
+0.117
View More